CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
December 2014—Affymetrix and Ariosa Diagnostics announced the signing of a multiyear supply agreement covering Affymetrix arrays and instruments to be used as part of Ariosa’s Harmony Non-Invasive Prenatal Test. The partnership enables Ariosa to pursue the development of a Harmony test kit that will allow laboratories worldwide to adopt and perform this test. The announcement follows the publication of a study in Fetal Diagnosis and Therapy online in which Ariosa’s scientists successfully tested and implemented Affymetrix microarrays as part of a DNA quantification method for the Harmony test. The study demonstrated better performance of Affymetrix microarrays in comparison to a next-generation sequencing approach in regard to shorter turnaround time and improved precision in measuring chromosome concentration and fetal fraction of cell-free DNA.
Affymetrix, 408-731-5000
Ariosa Diagnostics, 408-229-5180